Outset Medical's Hca Revenue Phasing, Next-Gen Tableau Launch Timeline Clash in 2026 Q2 Earnings Call

Date of Call: Aug 6, 2026

Financials Results

• Revenue: $31.6 million, up 1% year-over-year and up 14% sequentially
• Gross Margin: 42.2% non-GAAP, up over 380 basis points compared to last year

Guidance:

• Full-year 2026 revenue expected to be $125 million to $130 million, representing growth of 5% to 9% over last year.
• Most of the growth expected in the third and fourth quarters.
• Confidence supported by a strong commercial pipeline and the foundational contracted backlog from the HCA refresh agreement.

Business Commentary:

Revenue Performance and Growth Drivers:

• Outset Medical reported revenue of $31.6 million for Q2 2026, up 1% year-over-year and 14% sequentially.
• The growth was driven by steady execution in revenue, margin expansion, and successful new site implementations, as well as a strong commercial pipeline and contracted backlog from the HCA refresh agreement.

Product and Segment Performance:

• Product revenue was $21.9 million, down 5% year-over-year, while service and other revenue grew 17%.
• The decline in product revenue was due to a higher mix of console sales, whereas service revenue growth was driven by strong volume and average selling price increases.

Customer Satisfaction and Retention:

• The company conducted an independent customer assessment, resulting in an average score of 8.8 out of 10 for likelihood to recommend Outset.
• High customer satisfaction is attributed to the structured customer success approach and measurable results delivered by the clinical excellence team, leading to strong customer retention and expansion opportunities.

HCA Refresh Agreement and Future Opportunities:

• Outset signed a $40 million refresh agreement with HCA Healthcare, extending their commitment to in-source dialysis through 2028.
• This agreement validates the clinical and operational value of Tableau and provides contracted backlog, enhancing revenue predictability and supporting future growth.

Next-Generation Tableau Launch:

• The introduction of the next-generation Tableau system is anticipated to catalyze customer refresh decisions, with pilot phases currently underway.
• The new system offers hardware and software enhancements, including improved performance, reliability, and advanced cybersecurity capabilities, driving customer enthusiasm and expected high receptivity upon full launch.

Sentiment Analysis:

Overall Tone: Positive

• Management expressed confidence in commercial progress, citing steady execution, margin expansion, and strong customer advocacy (average NPS score of 8.8). The HCA $40 million refresh agreement was highlighted as a meaningful commercial win and validation, with expectations that new growth tailwinds (refresh cycle, next-gen launch, customer success team) will position the company well for future momentum.

Q&A:

• Question from Rick Wise (Stiefel): Unpack console revenue outperformance of $9.5M vs. consensus; how much tied to HCA agreement, early next-gen launch impact, vs. lingering capital orders?
  Response: Attributed to a combination of factors, including the HCA refresh agreement (part of Q2 pipeline), new expansion customers, and broad deal pipeline activity. Management noted 'all parts of the business performed as expected' and this quarter showed 'green shoots' from new growth tailwinds like the refresh opportunity and customer success program.

• Question from Rick Wise (Stiefel): Explain steeper consumable revenue decline of 12% YOY vs. prior quarter; impact of new systems, HCA, next-gen launch?
  Response: Decline due to tough prior-year comparisons (strong flu season in 2025 and prior-year ordering cadence) but utilization data remains stable. Expectation is for consumable revenue to align with total revenue growth in the back half of the year.

• Question from Rick Wise (Stiefel): Help understand revenue cadence in second half given $2.8M beat in Q2; is Q3 seasonally slower, with stronger Q4?
  Response: Management acknowledged some seasonality in MedTech, with Q3 often impacted by customer census and budget cycles, expecting a stronger Q4, which is typical for capital equipment businesses.

• Question from Brian (TD Cowan): Broadly discuss phasing of HCA refresh agreement across 2026-2028; is 2027 likely the biggest year for revenue recognition?
  Response: Company has visibility and included the agreement in its 2026 guidance but will not provide specifics on annual phasing. HCA agreement is part of a broader refresh cycle opportunity, and management expects future refresh deals and existing account penetration to contribute.

• Question from Brian (TD Cowan): Provide feedback from initial next-gen Tableau users and milestones for full launch.
  Response: Currently in pilot phase; focused on measured rollout to ensure perfect user experience and system performance. Enthusiasm from customers due to enhanced cybersecurity and improved user experience/clinician workflow. Full launch timing not specified, pending successful pilot metrics.

Contradiction Point 1

HCA Agreement Revenue Phasing

It involves differing statements on the revenue recognition timeline for the HCA agreement, specifically regarding whether 2027 will be the biggest year.

Brian (TD Cowan) - Brian (TD Cowan)

2026Q2: The agreement extends through 2028... No specific details on the phasing between 2027 and 2028 were disclosed due to customer confidentiality. - [Rene Gaeta](CFO)

Can you provide details on the phasing of the HCA refresh agreement across the three years and confirm if 2027 will be the largest year for revenue recognition? - Brian (TD Cowen)

2026Q2: Visibility is confirmed for 2026... The distribution across 2027 and 2028 will not be specified at this time. - [Renee Gaeta](CFO)

Contradiction Point 2

Full Launch Timeline for Next-Gen Tableau

It involves conflicting statements on the readiness and timing for a full launch of the next-gen Tableau system.

Brian (TD Cowan) - Brian (TD Cowan)

2026Q2: The pilot phase is currently underway... The full launch will proceed only after pilot metrics confirm the update meets all performance and user experience standards. - [Leslie Trigg](CEO)

What feedback have initial users provided for the next-gen Tableau system, and what milestones are needed before the full launch? - Brian (TD Cowen)

2026Q2: The pilot phase is currently underway. The company is taking a measured approach... Metrics from the pilot phase will guide the transition to full launch... - [Leslie Trigg](CEO)

Contradiction Point 3

Capital Order Timing and Pipeline Predictability

It involves differing views on the predictability and timing of capital sales, which affects financial forecasting and investor expectations.

Rick Wise (Stiefel) - Rick Wise (Stiefel)

2026Q2: All parts of the business performed as expected... with green shoots from new tailwinds like the refresh opportunity, new commercial leadership, and a formalized customer success program. - [Rene Gaeta](CFO)

What portion of the $9.5 million console revenue outperformance is attributed to the HCA agreement, the next-gen Tableau launch, or a Q1 revenue pull-forward? - Rick Wise (Stifel)

2026Q1: Capital sales timing is less predictable due to close timing variability, but the overall business performed as expected... - [Leslie Trigg](CEO)

Contradiction Point 4

Revenue Quarterly Phasing Expectations

It involves differing expectations for quarterly revenue growth trends, specifically for Q3 and Q4.

Rick Wise (Stiefel) - Rick Wise (Stiefel)

2026Q2: It is reasonable to assume Q3 could be impacted by seasonality, with Q4 expected to be a stronger quarter as the full year target is maintained. - [Rene Gaeta](CFO)

"Given the Q2 beat and midpoint revenue guidance, how should we model the cadence for the second half—will Q3 align with Q2 or will growth ramp in Q4?" - Rick Wise (Stifel)

2026Q1: Q2 revenue is expected to see a modest step-up sequentially. The majority of 2026 growth... is expected in Q3 and Q4, with some step-up growth likely between those quarters... - [Renee Gaeta](CFO)

Contradiction Point 5

Gross Margin Impact of Next-gen Tableau Launch

It involves inconsistent characterization of the financial impact of launching the next-generation product, specifically on gross margins.

Rick Wise (Stiefel) - Rick Wise (Stiefel)

2026Q2: The strong console performance in Q2 was driven by multiple factors, including the HCA refresh agreement... Additionally, there were new expansion customers and console placements. - [Rene Gaeta](CFO)

What portion of the $9.5 million outperformance in console revenue is attributed to the HCA agreement, the early impact of the next-gen Tableau launch, and a potential Q1 pull-forward? - Frederick Wise (Stifel)

20260212-2025 Q4: The company expects value from product innovation and customers will see value in the upgrade. Gross margin impact is expected to be relatively mild due to thoughtful design that allows for upgrades. - [Renee Gaeta](CFO)